Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. (Q39298856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Chengqiong Mao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Xiao-Jiao Du

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jin-Zhi Du

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Feng Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jun Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

9 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

5476-5480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22886872%20AND%20SRC:MED&resulttype=core&format=json

Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Recent advances in stealth coating of nanoparticle drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Tumor delivery of macromolecular drugs based on the EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

PEGylated nanoparticles for biological and pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

The effect of particle design on cellular internalization pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated Poly(amido amine)s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Bioresponsive polymers for the delivery of therapeutic nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Zwitterionic biocompatible quantum dots for wide pH stability and weak nonspecific binding to cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Small and stable sulfobetaine zwitterionic quantum dots for functional live-cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

A protein nanocarrier from charge-conversion polymer in response to endosomal pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Targeted charge-reversal nanoparticles for nuclear drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

pH-Responsive nanoparticles for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

A virus-mimetic nanogel vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Polymer therapeutics: concepts and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Thiol-ene click chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Functionalized micellar systems for cancer targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296

Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201202296